Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic
PedCan-COVID
1 other identifier
observational
800
1 country
1
Brief Summary
This is a prospective follow-up non-intervention study that will be carried out at Hematology/ Oncology Department, Children's hospital, Ain-Shams University, Cairo, Egypt. All followed-up children below 18 years with cancer during the one year study period from May 2020 till Apr 2021 either at the out-patients clinic or inpatient department will be recruited.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
May 25, 2020
CompletedFirst Posted
Study publicly available on registry
May 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedJanuary 12, 2024
January 1, 2024
3.8 years
May 25, 2020
January 10, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of COVID-19 among children with cancer
Measure the incidence of COVID-19 infection among children with cancer
12 months
Secondary Outcomes (1)
Families training
12 months
Eligibility Criteria
All followed-up children below 18 years with with malignancy either hematological or solid tumors or hematological condition during the one year study period from May 2020 till Apr 2021 either at the out-patients clinic or inpatient department will be recruited.
You may qualify if:
- Children below 18 years with malignancy either hematological or solid tumors or
- Children below 18 years with hematological condition
You may not qualify if:
- \. Patients or care-givers refusal to be enrolled in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center
Cairo, Non-US, 11566, Egypt
Related Publications (1)
Ebeid FSE, Ragab IA, Elsherif NHK, Makkeyah S, Mostafa S, Eltonbary K, Matbouly S, Mostafa A, Goma H, Agwa SH, Hafez HM, Girgis S, El Gendy YG, El-Sayed MH. COVID-19 in Children With Cancer: A Single Low-Middle Income Center Experience. J Pediatr Hematol Oncol. 2021 Nov 1;43(8):e1077-e1081. doi: 10.1097/MPH.0000000000002025.
PMID: 33290293RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Fatma Ebeid
Excuitive Director of MARSI-CRC
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Executive Director of Faculty of Medicine Ain Shams University Research Institute - Clinical Research Center
Study Record Dates
First Submitted
May 25, 2020
First Posted
May 27, 2020
Study Start
January 1, 2020
Primary Completion
November 1, 2023
Study Completion
January 1, 2024
Last Updated
January 12, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share